| |
Article Title |
Author(s) |
Pages |
|
|
|
Masthead
|
|
IFC
|
|
|
|
Officers
|
|
i
|
|
|
|
Table of Contents
|
|
ii-iii
|
|
| News and Views |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Intrapleural Therapy in Empyema Thoracis: A Contemporary Solution to an Age-Old Problem?
Infection within the pleural space has posed a management dilemma for physicians since the time of Hippocrates. Despite advances in medical treatment for pneumonia, the incidence of both complicated p...
|
David D. Odell,
Jonathan D'Cunha
|
257-258
|
|
|
|
Human Lung Stem Cells: Has the Future Arrived?
An intriguing paper was recently published that describes c-kit–positive human lung stem cells that self-renew and differentiate into multiple lineages. While these findings are potentially therapeuti...
|
Jennifer M. Hanna,
Mark W. Onaitis
|
259-260
|
|
|
|
Barrett's Esophagus and Cancer Risk: A More Realistic Estimate
The cancer risk in patients with Barrett's esophagus is important because it determines screening, surveillance, and treatment considerations. Previously, the risk of progression to esophageal adenoca...
|
Shanmugarajah Rajendra,
Prateek Sharma
|
261-262
|
|
|
|
Airway Stenting for Emphysema: Back to the Drawing Board
In a recent report, authors describe their findings from the Exhale Airway Stents for Emphysema (EASE) trial. In this study, investigators follow patients with emphysema and severe hyperinflation afte...
|
Mara B. Antonoff,
Jonathan D'Cunha
|
263-265
|
|
|
|
Partner IA: What It Means for Surgeons
Since commercialization of transcatheter aortic valves in 2007, there have been an estimated >40,000 valves implanted in patients in 42 countries outside of the United States. Despite this extensiv...
|
Michael Mack
|
266-267
|
|
|
|
Percutaneous Treatment of Mitral Regurgitation: Current Status and Future Directions
The burgeoning field of catheter-based, percutaneous valve intervention takes an interdisciplinary approach to mitral valve regurgitation with the goal of maximizing clinical outcomes and minimizing p...
|
Lori K. Soni,
Michael Argenziano
|
268-270
|
|
|
|
Innovative Clinical Trial Design in Cardiac Surgery
The landscape of cardiac surgery is continually and rapidly transformed by a high rate of innovation. Today, cardiac surgery represents a surgical specialty with a significant number of actively enrol...
|
Alexander Iribarne,
Annetine C. Gelijns,
Michael A. Acker,
Deborah D. Ascheim
|
271-273
|
|
| State of the Art |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Hybrid Options for Treating Cardiac Disease
The options for treating heart disease have greatly expanded during the course of the last 2 1/2 decades with the advent of hybrid technology. The hybrid option for treating cardiac disease implies us...
|
Ramanan Umakanthan,
Marzia Leacche,
David X. Zhao,
Anna H. Gallion,
Prabodh C. Mishra,
John G. Byrne
et al.
|
274-280
|
|
|
|
Personalized Therapy for Non-Small Cell Lung Cancer: Which Drug for Which Patient?
The elucidation of the molecular alterations in non-small cell lung cancer (NSCLC) and the development of molecularly targeted agents have permanently shifted NSCLC therapy to a personalized approach....
|
Liza C. Villaruz,
Mark A. Socinski
|
281-290
|
|
|
|
Current Surgical Therapy for Stage IIIA (N2) Non-Small Cell Lung Cancer
Local therapy alone (surgery or radiation) leads to poor overall survival in patients with stage III non-small cell lung cancer because most of these patients die of distant metastases. During the pas...
|
Jane Yanagawa,
Valerie W. Rusch
|
291-296
|
|
|
|
Chest Physiotherapy in Lung Resection Patients: State of the Art
The role of chest physiotherapy in limiting postoperative pulmonary complications and in the recovery of pulmonary function and exercise capacity after lung surgery is still unclear because of the lac...
|
Gonzalo Varela,
Nuria M. Novoa,
Paula Agostini,
Esther Ballesteros
|
297-306
|
|
|
|
Chest Wall Resection and Reconstruction According to the Principles of Biomimesis
Biomimesis has become the objective of the reconstructive strategies after chest wall resections for primary or secondary tumors. Biomimesis is pursued by respecting the anatomy, preserving function, ...
|
Gaetano Rocco
|
307-313
|
|
| Techniques My Way |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Myocardial Preservation: Beating Heart Techniques
Increased complexity of patients referred for cardiac surgery has led surgeons to develop new methods of myocardial protection. Together with improvements in anesthesia management and postoperative ca...
|
Francisco Igor B. Macedo,
Yilliam Rodriguez,
Tomas A. Salerno
|
314-317
|
|
|
|
Myocardial Preservation: Controlled Reperfusion
Reperfusion injury after reestablishing coronary flow by releasing the aortic cross clamp after cardiac surgery with cardioplegic arrest causes myocardial damage and even death. Attenuation of this re...
|
Prasanna Simha Mohan Rao,
Parimala Prasanna Simha
|
318-321
|
|
|
|
Introduction: Superior Vena Cava and Innominate Vein Reconstruction in Thoracic Malignancies
Thoracic malignancies have the potential to invade the superior vena cava (SVC) and innominate veins (IV). In the past, major vascular invasion was considered an operative contraindication; however, p...
|
Rafael S. Andrade
|
322
|
|
|
|
Superior Vena Cava and Innominate Vein Reconstruction in Thoracic Malignancies: Single-Vein Reconstruction
Benign or malignant disease processes involving the superior vena cava can be resected and reconstructed with excellent perioperative results and sustained durability.
|
Ikenna C. Okereke,
Kenneth A. Kesler
|
323-325
|
|
|
|
Superior Vena Cava and Innominate Vein Reconstruction in Thoracic Malignancies: Double-Vein Reconstruction
Extensive major venous resection and reconstruction with prosthetic vascular conduits are feasible with very good short- and long-term results. Okereke et al described the use of an externally stented...
|
David D. Odell,
Kenneth Liao
|
326-329
|
|
|
|
Superior Vena Cava and Innominate Vein Reconstruction in Thoracic Malignancies: Cryopreserved Graft Reconstruction
Recent technical advances in the domains of anesthesia, cardiovascular and thoracic surgery, and synthetic materials manufacturing coupled with more oncological extended tumor indications have unlocke...
|
Massimo Jaus,
Paolo Macchiarini
|
330-335
|
|
| Innovations and Challenges |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Managing Extreme Airway Size Mismatch in Lung Transplantation: The “Upper Lobectomy” Technique
Large size discrepancy between donor and recipient airway in lung transplantation presents a technical challenge. Most commonly, this mismatch presents as a smaller donor airway, particularly when mat...
|
Siva Raja,
Sudish C. Murthy,
Gosta B. Pettersson,
David P. Mason
|
336-338
|
|
|
|
Nonanatomical Mitral Valve Replacement in the Pulmonary Venous Confluence for Heavily Calcified Aortic or Mitral Annulus
Mitral valve replacement surgery after previous aortic valve surgery can be extremely challenging. The presence of heavy calcification and scarring in the aortic and/or mitral annulus can make suture ...
|
Brian E. Kogon,
Maan Jokhadar,
Anurag Sahu,
Micheal McConnell,
Wendy Book
et al.
|
339-341
|
|
